Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
June 29th, 2018 |
Partner Actions to Improve Oral Health Outcomes |
Centers for Disease Control NCCDPHP |
September 7th, 2021 |
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) |
National Institutes of Health |
May 1st, 2018 |
Rural Quality Improvement Technical Assistance Cooperative Agreement |
Health Resources and Services Administration |
March 27th, 2018 |
Service Area Competition-Additional Areas (SAC-AA) - Newark, NJ |
Health Resources and Services Administration |
November 3rd, 2020 |
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) |
National Institutes of Health |
January 25th, 2021 |
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) |
National Institutes of Health |
January 25th, 2021 |
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
National Institutes of Health |
January 25th, 2021 |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) |
National Institutes of Health |
March 26th, 2018 |
Evidence-Informed Approaches to Improving Health Outcomes for People Living with HIV |
Health Resources and Services Administration |
April 16th, 2018 |
The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed) |
National Institutes of Health |
April 3rd, 2018 |
Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 3rd, 2018 |
Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 4th, 2018 |
Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed) |
National Institutes of Health |
September 7th, 2021 |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
National Institutes of Health |
April 3rd, 2018 |
Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed) |
National Institutes of Health |
April 3rd, 2018 |
Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
April 3rd, 2018 |
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
April 3rd, 2018 |
Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2020 |
Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required) |
National Institutes of Health |
March 20th, 2018 |
Strengthening detection of emerging infectious diseases in India |
Centers for Disease Control and Prevention ERA |
|
March 20th, 2018 |
Quality Improvement in Newborn Screening Program |
Health Resources and Services Administration |
March 20th, 2018 |
Medications Development for the Treatment of Alcohol Use Disorder - CT optional (U01) |
National Institutes of Health |
March 19th, 2018 |
Clinical Support System for Serious Mental Illness Funding Opportunity Announcement (FOA) |
Substance Abuse and Mental Health Services Adminis |
May 7th, 2018 |
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01, Clinical Trial Optional) |
National Institutes of Health |
April 13th, 2018 |
PEPFAR HIV and AIDS Community Grants |
US Mission to South Africa |
April 5th, 2019 |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) |
National Institutes of Health |
April 5th, 2019 |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) |
National Institutes of Health |
April 5th, 2019 |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
National Institutes of Health |
March 7th, 2018 |
Pediatric Device Consortia Grants Program (P50) |
Food and Drug Administration |
March 22nd, 2018 |
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01, Clinical Trials Not Allowed) |
National Institutes of Health |
April 5th, 2019 |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
National Institutes of Health |
June 22nd, 2020 |
Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 5th, 2021 |
Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42) |
National Institutes of Health |
June 5th, 2020 |
New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed) |
National Institutes of Health |
December 4th, 2020 |
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional) |
National Institutes of Health |
April 12th, 2018 |
Health Workforce Research Center Cooperative Agreement Program |
Health Resources and Services Administration |
June 8th, 2020 |
Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 - Clinical Trial Optional) |
National Institutes of Health |
January 5th, 2021 |
Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
March 26th, 2018 |
Patient Safety Learning Laboratories: Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) |
Agency for Health Care Research and Quality |
December 4th, 2020 |
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional) |
National Institutes of Health |